ENDE

Account

Overview · Filed: Jun 26, 2024

UPC_APP_34720/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsOther ProceduralMunich LDGenericCase Closed

Overview Decisions Documents Timeline

Parties

Claimants

Medac Gesellschaft für klinische Spezialpräparate m.b.H.

Respondents

Sanofi Mature IP(Sanofi Group)
Sanofi Winthrop Industrie(Sanofi Group)
Sanofi-Aventis France(Sanofi Group)
Sanofi-Aventis GmbH(Sanofi Group)
Sanofi Belgium(Sanofi Group)
Sanofi-Aventis Deutschland GmbH(Sanofi Group)
Sanofi S.r.l.(Sanofi Group)
Sanofi B.V.(Sanofi Group)
Sanofi - Produtos Farmaceuticos Lda(Sanofi Group)
Sanofi AB(Sanofi Group)
Sanofi A/S(Sanofi Group)
STADAPHARM GmbH(Sanofi Group)
STADA Arzneimittel AG(Sanofi Group)
STADA Nordic ApS(Sanofi Group)

Judges

Matthias Zigann
Alima Zana
Tobias Pichlmaier
Carola Wagner

Patents

EP2493466

CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Sector: Pharmaceutical & Medical

Outcome

—

Filed: Jun 26, 2024

First decided: —

Language: English

Open on UPC Registry